Delivered within 72 hours
nuragen

Aesthetic pathway

Glow

BPC-157, TB-500 & GHK-Cu blend

£170

In stock · ships within 24 hours

Buy now

Delivered within 72 hours across the UK.

Supplied for qualified professional and laboratory research use only. Not a medicine and not for human or animal consumption.

Laboratory verification

Nothing unverified is published

Every compound is prepared to a documented standard. Independent certificates of analysis are published here per batch as they are verified under Nuragen's own governance, we do not reuse another brand's certificates or purity figures.

Certificate pending upload

Certificate of analysis · per batch · on request

Verification-led release

Glow is a research-use-only blend of three peptides: BPC-157, TB-500 and the copper peptide GHK-Cu. It is studied within the aesthetic pathway, where the research literature examines skin repair and tissue remodelling processes.

How it is studied

Glow brings together three peptides that are each investigated in the wider repair and remodelling literature. Studies in this area typically look at how these compounds signal within cellular pathways associated with tissue maintenance and extracellular matrix organisation. As a combined preparation, it is handled as a single research material for laboratory investigation. Any characterisation of how the three components behave together remains a matter for controlled study rather than assumption.

The components and the pathway

BPC-157 is a synthetic peptide studied in models of tissue repair and cellular signalling. TB-500 is a fragment related to thymosin beta-4, researched for its association with actin regulation and cell migration. GHK-Cu is a naturally occurring copper-binding peptide examined in the literature for its role in collagen and extracellular matrix processes. Grouped here as an aesthetic pathway blend, the components are studied in relation to skin repair and remodelling mechanisms.

How it sits in a responsible research programme

Glow is intended for laboratory and research settings only, where materials are documented, stored correctly and handled by qualified personnel. It is supplied without dosing guidance, protocols or any suggestion of use beyond controlled study. A responsible programme treats a multi-peptide preparation as a defined variable to be characterised, keeping records of handling conditions and separating what the research literature reports from what a given experiment can support.

Composition

ComponentCASPurity
BPC-157137525-51-0Pending
TB-50077591-33-4Pending
GHK-Cu49557-75-7Pending

In context

Evidence before action

A blend of three peptides raises more questions than any single compound, because their individual research contexts do not automatically describe how they behave in combination. The measured approach is to read each component against its own literature, note where evidence is preliminary, and let controlled study rather than expectation guide interpretation. This is what evidence-led means in practice: understanding what a material is studied to do before drawing any conclusion. Science, made accountable.

Glow£170
Buy now